|
|
 |
|
Viewing report
|
|
|
|
Altus Pharmaceuticals Inc.: SWOT Analysis & Company Profile
Business Review, Nov 2010, Pages: 22
Synopsis
Business Review’s Altus Pharmaceuticals Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Altus Pharmaceuticals Inc.’s business.
Business Review’s “Altus Pharmaceuticals Inc. SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Altus Pharmaceuticals Inc.) for business intelligence requirements
- Studies and presents Altus Pharmaceuticals Inc.’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Altus Pharmaceuticals Inc. (Altus) is a biopharmaceutical company engaged in the development and commercialization of drugs for gastrointestinal and metabolic disorders. Altus develops orally-delivered and injectable protein replacement products using its patented protein crystallization technology. Their products are used in the treatment of exocrine pancreatic insufficiency, growth hormone deficiency, hGH-related disorders, kidney stones, gout and phenylketonuria. The product line of the company includes Trizytek, ALTU-238, ALTU-237, ALTU-236 and ALTU-242. The company is headquartered in Massachusetts, United States.
|
|
|
|
